Skip to main content
DAVITA INC. logo

DAVITA INC. — Investor Relations & Filings

Ticker · DVA ISIN · US23918K1088 LEI · M2XHYMU3TZNEZURC6H66 US Human health and social work activities
Open in API
Filings indexed 2,061 across all filing types
Latest filing 2024-05-02 Interim / Quarterly Rep…
Country US United States of America
Listing US DVA

About DAVITA INC.

https://www.davita.com/

DaVita Inc. is a healthcare provider specializing in kidney care services. The company offers a range of treatments for patients with chronic kidney disease and end-stage kidney disease, primarily through a network of outpatient dialysis centers. Its core service is providing life-sustaining dialysis, including in-center hemodialysis and peritoneal dialysis. In addition to clinical treatments, DaVita provides integrated health care management and extensive patient support. This includes educational resources, tools, and dietary guidance to help individuals manage their kidney health throughout their entire disease journey. The company focuses on delivering holistic and equitable care to improve the quality of life for its patients.

Recent filings

Filing Released Lang Actions
10-Q
Interim / Quarterly Report Q1 2024
2024-05-02 English
8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated May 2, 2024, reporting the issuance of a press release announcing financial results for the quarter ended March 31, 2024. The text explicitly states that the press release is furnished as an exhibit and is not considered filed for certain regulatory purposes. The document is short (3565 characters) and primarily serves to announce the earnings release rather than containing detailed financial statements or analysis itself. According to the rules, such a document announcing financial results with a press release is classified as an Earnings Release (ER).
2024-05-02 English
8-K
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content describes the entry into a material definitive agreement regarding a share repurchase agreement with Berkshire Hathaway Inc. It details the terms of the agreement and references the filing of the agreement as an exhibit. There are no financial statements or comprehensive financial data presented, nor is this an earnings release or annual/interim report. The primary focus is on a capital transaction involving share repurchases. Therefore, the document fits best under the category of Capital/Financing Update (CAP). The document length is over 5,000 characters and contains substantive information about the financing agreement, not just an announcement of a report, so it is not an RPA or RNS.
2024-05-01 English
ANNUAL REPORT TO SECURITY HOLDERS
Annual Report
2024-04-26 English
DEFA14A
Proxy Solicitation & Information Statement Classification · 100% confidence The document is identified as a Schedule 14A filing, which is a proxy statement filed pursuant to Section 14(a) of the Securities Exchange Act of 1934. The text explicitly mentions it is a "Definitive Additional Materials" filing related to a proxy statement for DaVita Inc. Proxy statements are materials sent to shareholders to provide information and request votes for meetings. The document length is short (1944 characters), and it is clearly a proxy solicitation document rather than an annual report, earnings release, or other financial report. Therefore, the correct classification is Proxy Solicitation & Information Statement (PSI).
2024-04-26 English
DEF 14A
Proxy Solicitation & Information Statement
2024-04-26 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.